Susquehanna International Group
FRTX

Susquehanna International Group’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Susquehanna International Group’s Portfolio FRTX Stock Details FRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-33
Closed -$12K – 10473
2018
Q2 		$12K Buy
+33
New +$15.5K ﹤0.01% 9461
2016
Q4 		– Sell
-61
Closed -$58K – 10318
2016
Q3 		$58K Buy
+61
New +$77K ﹤0.01% 8086
2015
Q3 		– Sell
-5
Closed -$11K – 10349
2015
Q2 		$11K Buy
+5
New +$15.7K ﹤0.01% 10027
2015
Q1 		– Sell
-10
Closed -$32K – 10064
2014
Q4 		$32K Buy
10
+2
+25% +$7.08K ﹤0.01% 9442
2014
Q3 		$29K Sell
8
-3
-27% -$11.7K ﹤0.01% 9299
2014
Q2 		$42K Sell
11
-6
-35% -$22.6K ﹤0.01% 9617
2014
Q1 		$67K Sell
17
-6
-26% -$26.8K ﹤0.01% 8667
2013
Q4 		$84K Sell
23
-45
-66% -$170K ﹤0.01% 8685
2013
Q3 		$268K Buy
68
+20
+42% +$150K ﹤0.01% 7378
2013
Q2 		$474K Buy
+48
New +$532K ﹤0.01% 6118

Other funds holding FRTX

TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group's FRTX Position: Q3 2022 in Review

Susquehanna International Group sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q3 2022, closing a stake of 749 shares — an estimated $4K sold.

Susquehanna International Group first reported a position in FRTX in Q4 2013 and held it in 14 quarters. The position peaked at $78K in Q3 2018. 17 funds tracked by Wall St. Rank hold FRTX as of Q3 2022.

  • Susquehanna International Group reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Susquehanna International Group sold 749 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $4K.
  • Susquehanna International Group first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q4 2013 and held it in 14 quarters.
  • Susquehanna International Group's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $78K in Q3 2018.
  • 17 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Susquehanna International Group's 13F filing for Q3 2022, filed 14 Nov 2022.